These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33889083)

  • 1. Transneuronal Degeneration in the Brain During Glaucoma.
    You M; Rong R; Zeng Z; Xia X; Ji D
    Front Aging Neurosci; 2021; 13():643685. PubMed ID: 33889083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of retinal ganglion cell death in glaucoma.
    Almasieh M; Wilson AM; Morquette B; Cueva Vargas JL; Di Polo A
    Prog Retin Eye Res; 2012 Mar; 31(2):152-81. PubMed ID: 22155051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurobiology of cell death in glaucoma.
    Vrabec JP; Levin LA
    Eye (Lond); 2007 Dec; 21 Suppl 1():S11-4. PubMed ID: 18157171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions.
    Liu M; Duggan J; Salt TE; Cordeiro MF
    Exp Eye Res; 2011 Apr; 92(4):244-50. PubMed ID: 21310146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma and optic nerve repair.
    Diekmann H; Fischer D
    Cell Tissue Res; 2013 Aug; 353(2):327-37. PubMed ID: 23512141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension.
    Zhang S; Wang H; Lu Q; Qing G; Wang N; Wang Y; Li S; Yang D; Yan F
    Brain Res; 2009 Dec; 1303():131-43. PubMed ID: 19765568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration.
    Kang EY; Liu PK; Wen YT; Quinn PMJ; Levi SR; Wang NK; Tsai RK
    Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases.
    Zhang N; He X; Xing Y; Yang N
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1807-1821. PubMed ID: 35038014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy in axonal degeneration in glaucomatous optic neuropathy.
    Munemasa Y; Kitaoka Y
    Prog Retin Eye Res; 2015 Jul; 47():1-18. PubMed ID: 25816798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of retinal ganglion cell development, survival, and regeneration.
    Isenmann S; Kretz A; Cellerino A
    Prog Retin Eye Res; 2003 Jul; 22(4):483-543. PubMed ID: 12742393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic and clinical studies of pressure-independent damaging factors of open angle glaucoma].
    Araie M
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):213-36; discussion 237. PubMed ID: 21476309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.
    Wareham LK; Dordea AC; Schleifer G; Yao V; Batten A; Fei F; Mertz J; Gregory-Ksander M; Pasquale LR; Buys ES; Sappington RM
    Neurobiol Dis; 2019 Jan; 121():65-75. PubMed ID: 30213732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton-DAPI approach.
    Lei Y; Garrahan N; Hermann B; Becker DL; Hernandez MR; Boulton ME; Morgan JE
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1940-5. PubMed ID: 18436826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension.
    Vidal-Sanz M; Galindo-Romero C; Valiente-Soriano FJ; Nadal-Nicolás FM; Ortin-Martinez A; Rovere G; Salinas-Navarro M; Lucas-Ruiz F; Sanchez-Migallon MC; Sobrado-Calvo P; Aviles-Trigueros M; Villegas-Pérez MP; Agudo-Barriuso M
    Front Neurosci; 2017; 11():235. PubMed ID: 28491019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural compounds and retinal ganglion cell neuroprotection.
    Morrone LA; Rombolà L; Corasaniti MT; Bagetta G; Nucci C; Russo R
    Prog Brain Res; 2015; 220():257-81. PubMed ID: 26497795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of APOE in glaucoma.
    Yi W; Lv D; Sun Y; Mu J; Lu X
    Biochem Biophys Res Commun; 2024 Jan; 694():149414. PubMed ID: 38145596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Oxidative Stress as Potential Therapeutic Approach for Normal Tension Glaucoma.
    Harada C; Noro T; Kimura A; Guo X; Namekata K; Nakano T; Harada T
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32947996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychophysical testing in rodent models of glaucomatous optic neuropathy.
    Grillo SL; Koulen P
    Exp Eye Res; 2015 Dec; 141():154-63. PubMed ID: 26144667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of inducible heat shock proteins Hsp27 and Hsp70 in the visual pathway of rats subjected to various models of retinal ganglion cell injury.
    Chidlow G; Wood JP; Casson RJ
    PLoS One; 2014; 9(12):e114838. PubMed ID: 25535743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension.
    Zhou L; Chen W; Lin D; Hu W; Tang Z
    Exp Eye Res; 2019 Mar; 180():77-85. PubMed ID: 30562486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.